Mechanistic analysis of Zein nanoparticles/PLGA triblock in situ forming implants for glimepiride.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26893561)

Published in Int J Nanomedicine on February 03, 2016

Authors

Osama Abdelhakim Aly Ahmed1, Ahmed Samir Zidan2, Maan Khayat3

Author Affiliations

1: Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Minia University, Minia, Egypt.
2: Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.
3: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.

Articles cited by this

Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J Control Release (2001) 1.85

Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive gels on vaginitis. J Control Release (2002) 1.15

Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting. Int J Pharm (2010) 1.12

Protein-based nanocarriers as promising drug and gene delivery systems. J Control Release (2012) 1.10

Simple coacervates of zein to encapsulate Gitoxin. Colloids Surf B Biointerfaces (2006) 0.95

Systematic study of the flow behaviour and mechanical properties of Carbopol Ultrez 10 hydroalcoholic gels. Eur J Pharm Biopharm (2002) 0.94

Emerging protein delivery methods. Curr Opin Biotechnol (2001) 0.94

PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release. J Control Release (2013) 0.90

Controlled release of insulin from injectable biodegradable triblock copolymer. Pharm Res (2001) 0.89

Design and evaluation of chitosan films for transdermal delivery of glimepiride. Curr Drug Deliv (2008) 0.88

Status of surfactants as penetration enhancers in transdermal drug delivery. J Pharm Bioallied Sci (2012) 0.88

New formulation approaches to improve solubility and drug release from fixed dose combinations: case examples pioglitazone/glimepiride and ezetimibe/simvastatin. Eur J Pharm Biopharm (2012) 0.88

Didodecyldimethylammonium bromide lipid bilayer-protected gold nanoparticles: synthesis, characterization, and self-assembly. Langmuir (2006) 0.87

In vitro release of insulin and biocompatibility of in situ forming gel systems. Int J Pharm (2005) 0.85

Spectroscopic characterization and structural modeling of prolamin from maize and pearl millet. Eur Biophys J (2003) 0.83

Three-dimensional structure of maize alpha-zein proteins studied by small-angle X-ray scattering. Biochim Biophys Acta (1997) 0.82

Design of a long-term antipsychotic in situ forming implant and its release control method and mechanism. Int J Pharm (2012) 0.82

Direct stimulation of myocardial glucose transport and glucose transporter-1 (GLUT1) and GLUT4 protein expression by the sulfonylurea glimepiride. Endocrinology (1995) 0.81

Strategies to improve dissolution and oral absorption of glimepiride tablets: solid dispersion versus micronization techniques. Drug Dev Ind Pharm (2011) 0.80

Adding glimepiride to current insulin therapy increases high-molecular weight adiponectin levels to improve glycemic control in poorly controlled type 2 diabetes. Diabetol Metab Syndr (2014) 0.80

Cosolvent effects on the drug release and depot swelling in injectable in situ depot-forming systems. J Pharm Sci (2012) 0.78

Kinetics of drug release from ointments: Role of transient-boundary layer. Int J Pharm (2015) 0.78

Solvent exchange-induced in situ forming gel comprising ethyl cellulose-antimicrobial drugs. Int J Pharm (2015) 0.78

Optimized zein nanospheres for improved oral bioavailability of atorvastatin. Int J Nanomedicine (2015) 0.77